be0146 critical (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
99
Structured Review
Bio X Cell
be0146 critical
Be0146 Critical, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 99/100, based on 1283 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivomab+anti+mouse+pd/InVivoMAb+anti-mouse+PD-1/pm42789388-293-49-47
Average 99 stars, based on 1283 article reviews
Be0146 Critical, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 99/100, based on 1283 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivomab+anti+mouse+pd/InVivoMAb+anti-mouse+PD-1/pm42789388-293-49-47
Average 99 stars, based on 1283 article reviews
be0146 critical - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Injection:Article Title: Modified IL-2 polypeptides and uses thereof Article Snippet: Animals treated with anti-PD-1 antibody received 10 mL/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of InVivoMAb anti-mouse PD-1/CD279 (Clone RMP1-14; BioXcell; Cat #BE0146) twice per week over three weeks. .. Finally, animals treated with a combination of composition D and anti-PD-1 antibody received a single 10 mL/kg bolus intravenous (i.v.) injection of 3 mg/kg (184 nmoles/kg) of modified IL-2 polypeptides on day 0, 7, and 14 and 10 ml/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of Article Title: Modified IL-2 polypeptides and uses thereof Article Snippet: Animals treated with anti-PD-1 antibody received 10 mL/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of InVivoMAb anti-mouse PD-1/CD279 (Clone RMP1-14; BioXcell; Cat #BE0146) twice per week over three weeks. .. Finally, animals treated with a combination of composition D and anti-PD-1 antibody received a single 10 mL/kg bolus intravenous (i.v.) injection of 3 mg/kg (184 nmoles/kg) of modified IL-2 polypeptides on day 0, 7, and 14 and 10 ml/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of Modification:Article Title: Modified IL-2 polypeptides and uses thereof Article Snippet: Animals treated with anti-PD-1 antibody received 10 mL/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of InVivoMAb anti-mouse PD-1/CD279 (Clone RMP1-14; BioXcell; Cat #BE0146) twice per week over three weeks. .. Finally, animals treated with a combination of composition D and anti-PD-1 antibody received a single 10 mL/kg bolus intravenous (i.v.) injection of 3 mg/kg (184 nmoles/kg) of modified IL-2 polypeptides on day 0, 7, and 14 and 10 ml/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of Article Title: Modified IL-2 polypeptides and uses thereof Article Snippet: Animals treated with anti-PD-1 antibody received 10 mL/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of InVivoMAb anti-mouse PD-1/CD279 (Clone RMP1-14; BioXcell; Cat #BE0146) twice per week over three weeks. .. Finally, animals treated with a combination of composition D and anti-PD-1 antibody received a single 10 mL/kg bolus intravenous (i.v.) injection of 3 mg/kg (184 nmoles/kg) of modified IL-2 polypeptides on day 0, 7, and 14 and 10 ml/kg bolus intraperitoneal (i.p.) injections of 10 mg/kg of other:Article Title: ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy. Article Snippet: In this study, we developed a ROS-responsive thermosensitive poly(ethylene glycol)-polypeptide hydrogel loaded with a chemotherapeutic drug, doxorubicin (Dox), an antiviral imidazoquinoline, resiquimod (R848), and antibody targeting programmed cell death protein 1 (aPD-1) for local chemoimmunotherapy.. The hydrogel demonstrated controllable degradation and sustained drug release behavior according to the concentration of ROS in vitro.. Following intratumoral injection into mice bearing B16F10 melanoma, the Dox/R848/aPD-1 co-loaded hydrogel effectively inhibited tumor growth, prolonged animal survival time and promoted anti-tumor immune responses with low systemic toxicity. |
